CAS: 1020349-31-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Hexahydro-oxazolo[3,4-a]pyrazin-3-one hydrochloride REF: 10-F050125CAS: 1020349-31-8 | 95.0% | To inquire | Thu 25 Jul 24 |
 | hexahydro-1H-[1,3]oxazolo[3,4-a]piperazin-3-one hydrochloride REF: 3D-VQB34931CAS: 1020349-31-8 | Min. 95% | To inquire | Mon 26 Aug 24 |
 | 3H-Oxazolo[3,4-a]pyrazin-3-one, hexahydro-, hydrochloride (1:1) REF: AN-AG0006F7CAS: 1020349-31-8 | 97% | - - - | Discontinued product |
![Hexahydro-oxazolo[3,4-a]pyrazin-3-one hydrochloride](https://static.cymitquimica.com/products/10/thumb/F050125.jpg)
Hexahydro-oxazolo[3,4-a]pyrazin-3-one hydrochloride
CAS:1020349-31-8
Purity:
95.0%
Color and Shape:
Solid, solid
Molecular weight:
178.6199951171875
Ref: 10-F050125
| 1g | To inquire | ||
| 10g | To inquire | ||
| 250mg | 83.00 € |
Estimated delivery in United States, on Thursday 25 Jul 2024
![hexahydro-1H-[1,3]oxazolo[3,4-a]piperazin-3-one hydrochloride](https://static.cymitquimica.com/products/3D/thumb/VQB34931.jpg)
hexahydro-1H-[1,3]oxazolo[3,4-a]piperazin-3-one hydrochloride
CAS:1020349-31-8
Acetyl-L-carnitine is an acetamide derivative of the amino acid carnitine. It is a choline ester …
Formula:
C6H11ClN2O2
Purity:
Min. 95%
Molecular weight:
178.6 g/mol
Ref: 3D-VQB34931
| 1g | To inquire | ||
| 5g | To inquire | ||
| 10g | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Monday 26 Aug 2024
![3H-Oxazolo[3,4-a]pyrazin-3-one, hexahydro-, hydrochloride (1:1)](https://static.cymitquimica.com/products/AN/thumb/AG0006F7.jpg)
3H-Oxazolo[3,4-a]pyrazin-3-one, hexahydro-, hydrochloride (1:1)
CAS:1020349-31-8
Formula:
C6H11ClN2O2
Purity:
97%
Color and Shape:
Solid
Molecular weight:
178.6167
Ref: AN-AG0006F7
| 1g | Discontinued | Request information | |
| 5g | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
